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Repetitive mild traumatic brain injury (mTBI) is a risk factor for the development of
neurodegenerative diseases such as chronic traumatic encephalopathy typified by
immunoreactive tau aggregates in the depths of the sulci. However, the underlying
neurobiological mechanisms involved have not been largely explored. Phospholipids
are important molecules which form membrane lipid bilayers; they are ubiquitous
to every cell in the brain, and carry out a host of different functions. Imbalance in
phospholipid metabolism, signaling and transport has been documented in some
neurological conditions. However, not much is currently known about their roles in
repetitive mTBI and how this may confer risk for the development of age-related
neurodegenerative diseases. To address this question, we designed a longitudinal
study (24 h, 3, 6, 9, and 12 months post-injury) to comprehensively investigate mTBI
dependent brain phospholipid profiles compared to sham counterparts. We use our
established mouse model of repetitive mTBI that has been extensively characterized
up to 1-year post-injury in humanized tau (hTau) mice, which expresses all six human
tau isoforms, on a null murine background. Our data indicates a significant increase in
sphingomyelin, phosphatidylethanolamine (PE), phosphatidylcholine (PC), and derivative
lysoPE and lysoPC at acute and/or sub-acute time points post-injury within the
cortex and hippocampus. There was also a parallel increase at early time points in
monounsaturated, polyunsaturated and saturated fatty acids. Omega-6 (arachidonic
acid) to omega-3 (docosahexaenoic acid) fatty acid ratio for PE and PC species was
increased also at 24 h and 3 months post-injury in both hippocampus and cortex. The
long-term consequences of these early changes in phospholipids on neuronal and non-
neuronal cell function is unclear, and warrants further study. Understanding phospholipid
metabolism, signaling and transport following TBI could be valuable; they may offer novel
targets for therapeutic intervention not only in TBI but other neurodegenerative diseases.
Keywords: repetitive mild traumatic brain injury, hTau, cortex, hippocampus, phospholipids, omega-3 and 6 fatty
acids, arachidonic acid, docosahexaenoic acid
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INTRODUCTION
Exposure to a history of repetitive mild traumatic brain
injury (mTBI) has been recognized as a major risk factor
for the development of age-related degenerative diseases, such
as Alzheimer’s disease, and chronic traumatic encephalopathy
(CTE) typified by immunoreactive tau aggregates in the depths
of the sulci (Gedye et al., 1989; Mortimer et al., 1991; Schofield
et al., 1997; Fleminger et al., 2003; McKee et al., 2013; Omalu
et al., 2011; Smith et al., 2013). The underlying neurobiological
mechanisms that precipitates these disease phenotypes have not
been largely explored.
Lipidomic profiling is an extremely powerful tool that enables
large-scale study of novel pathways and networks of lipids
in biological systems (Sparvero et al., 2010; Wenk, 2010). It
has been utilized very successfully in recognizing the roles
of lipids in several metabolic diseases such as atherosclerosis,
hypertension and diabetes, but to date has received little attention
in the study of neurodegenerative disorders. The brain is
one of the richest tissues in terms of phospholipid content.
Phospholipids are important molecules, forming the membrane
lipid bilayers of neurons, glia and cerebrovascular cells. They
provide structural integrity for intracellular and cell surface
membrane proteins (Adibhatla and Hatcher, 2007). They have
a host of diverse roles ranging from regulating behavior of
membrane proteins, receptors, enzymes, ion channels, serving as
bioenergetics reservoirs and precursors of secondary messengers
for signal transduction, including mediating inflammatory
responses (Adibhatla and Hatcher, 2007). An imbalance in
the coordination of phospholipid metabolism has been well
documented in several neurological and psychiatric conditions,
resulting in diverse phenotypes and disease states (Kosicek and
Hecimovic, 2013). In human severe TBI cases, increases in
phospholipid levels from lipoprotein fractions, and free fatty
acids in the CSF have been reported within hours to days
after injury (Pilitsis et al., 2003; Pasvogel et al., 2010; Hankin
et al., 2011). Also severe TBI mouse models involving controlled
cortical injury (CCI) show increased levels of phospholipids
and their metabolites in the brain at acute to sub-acute time
points post-injury (Homayoun et al., 1997, 2000; Abdullah
et al., 2014). There are, however, no current studies that
have explored the role of phospholipids in repetitive mTBI,
especially at chronic time points post-injury, and how this may
confer risk for the development of age-related neurodegenerative
diseases.
To address this question herein, we designed a prospective
and longitudinal study to comprehensively investigate
repetitive mTBI dependent and age-related changes in the
brain (hippocampus and cortex) phospholipid profiles in a
preclinical mouse model. We focus on time points 24 h, 3,
6, 9, and 12 months post-injury to cover the span of acute,
sub-acute and chronic changes following TBI. We have chosen
to use our previously established mouse model of repetitive
mTBI with 5 hits administered to young mice over a 2-week
period. This model has been extensively characterized from
24 h to 24 months post-injury. Animals demonstrate persistent
deficits in spatial memory, and white matter damage typified by
corpus callosum thinning, axonal injury and gliosis (Mouzon
et al., 2012; Ojo et al., 2013; Mouzon et al., 2014; Ojo et al.,
2015, 2018). Given the involvement of tau in CTE, and our
previous reports of TBI dependent tau pathology following
TBI in tau transgenic mice (Ojo et al., 2013, 2016; Mouzon
et al., 2018a,b,c), we have chosen to use the hTau mice which
expresses all six isoforms of human tau, on a null murine
background to closely mimic the human condition (Andorfer
et al., 2003).
We report in this first study, a significant increase
in sphingomyelin, phosphatidylethanolamine (PE),
phosphatidylcholine (PC), and derivative lysoPE and lysoPC
at acute and/or sub-acute time points post-injury within the
cortex and hippocampus. There was also a parallel increase at
early time points in monounsaturated, polyunsaturated and
saturated fatty acids. The omega-6 (arachidonic acid) to omega-3
(docosahexaenoic acid) fatty acid ratios for PE and PC species
were increased also at 24 h and 3 months post-injury in the both
hippocampus and cortex. The long-term consequences of these
early phospholipid changes on neuronal and non-neuronal cell
function is unclear, but warrants further study. Understanding
phospholipid metabolism, signaling and transport could be
valuable to the study of TBI, as they may offer a novel targets and
indicate the appropriate or optimum time frame for therapeutic
intervention.
MATERIALS AND METHODS
Animals
Transgenic mice expressing human tau on a C57BL/6 and null
murine tau background (generated as previously described by
Andorfer et al., 2003) were purchased from Jackson Laboratories,
Bar Harbor, ME, United States. Animals were 12 weeks old
prior to injury exposure. Animals were housed in standard cages
under a 12-h light/12-h dark schedule at ambient temperature
controlled between 22 and 23◦C under specific pathogen free
conditions. Animals were given food and water ad libitum and
maintained under veterinary supervision throughout the study.
There was no evidence of disease among the colony. Male mice
were randomly assigned to experimental groups consisting of
a sample size of 4 per group. All mice were male to avoid
any confounding effects of gender and to limit the numbers of
mice required. Experiments were performed in accordance with
Office of Laboratory Animal Welfare and National Institutes of
Health guidelines under a protocol approved by the Roskamp
Institute Institutional Animal Care and Use Committee (IACUC
- R054). All analyses were carried out blind to study group
assignment.
Experimental mTBI
The experimental TBI methods were performed as previously
described (Mouzon et al., 2012). Briefly, mice were anesthetized
with 1.5 L per minute of oxygen and 3% isoflurane for 3 min.
After shaving of the injury site, mice were transferred into a
stereotaxic frame (Just For Mice Stereotaxic, Stoelting, Wood
Dale, IL, United States) mounted with an electromagnetic
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controlled impact device (Impact One Stereotaxic Motorized
Impactor, Richmond, IL, United States). Heads were positioned
and fixed in the device, which prevented lateral movements as
the impact was delivered. All mice were placed on a heating pad
to maintain their body temperature at 37(C. A 5-mm blunt metal
impactor tip attached to the electromagnetic motorized device
was zeroed on the scalp and positioned above the midsagittal
suture before each impact using the NeuroLab controller. On
satisfactory positioning, the tip was retracted and the depth was
adjusted to the desired level. The scalp was gently stretched by
hand to restrict lateralization of the impact and to prevent the
rod from delivering an inadequate trauma load at an irregular
angle. Injury parameters were 5 m per second strike velocity,
1.0 mm strike depth, 200 milliseconds dwell time, and a force of
72N. This sublethal impact does not cause direct tissue damage
to the injury site, and there is no development of skull fracture
or subdural hemorrhage, even after repetitive injuries. Mice in
the r-TBI group received 5 hits over a 9-day period with an
inter-injury interval of 48 hours. Repetitive sham control mice
received anesthesias of the same frequency and duration ((˜3
mins per session) as their r-TBI counterparts. After each impact
was delivered, the mice were allowed to recover on a heating pad
set at 37(C to prevent hypothermia. On becoming ambulatory,
mice were returned to their cages and carefully monitored for any
abnormalities.
Lipidomic Analyses
Anesthetized animals at euthanasia were sacrificed by cardiac
puncture, and perfused transcardially with phosphate buffer
saline solution. Brain tissue was removed and cortices were
dissected and flash frozen in liquid nitrogen. Cortices were
homogenized in LC/MS grade water in a volume of 2.5×
wet weight. Fifty microliter aliquots were stored specifically
for lipidomic analysis. The Folch method (Folch et al., 1957)
was used to extract lipids from brain samples spiked with
synthetic internal standards [di-14:0 FA containing PC and
PE, 14:0 FA containing (LPE) and (LPC), d18:1/17:0 SM,
and di-16:0 for PI]. Dried lipid extracts were re-suspended
in isopropanol and separation was achieved using hydrophilic
interaction chromatography (HILIC) on a 1 mm × 100 mm
column packed with 3 µm Pinnacle II silica particles (Restek
Corporation, Bellefonte, PA, United States). An isocratic run was
performed with 70% solvent A [100% acetonitrile (ACN)] in
30% solvent B (78% methanol, 1% formic acid, 0.6% ammonium
hydroxide) for 15 min at a flow rate of 55µl/min with the column
temperature at 40◦C. Mass spectrometry (MS) was performed
with a Thermo LTQ-XL linear ion trap mass spectrometer
equipped with a Surveyor HPLC pumping system and Micro
AS autosampler (Thermo Fisher, Waltham, MA, United States).
Full scan negative ion mass spectra were acquired from m/z 200
to 2,000 with in-source collision induced dissociation (SCID),
with relative energies at 15%. All spectra were obtained with a
200 ms maximum ion time and by summing of 5 microscans.
Mass spectra were summed over the chromatographic peak for
each PL class and spectra (each as a list of m/z versus intensity
signal) and were exported from the XCalibur (Thermo Fisher)
to Microsoft Excel (Microsoft, Redmond, WA, United States).
Files were then uploaded to LipidomeDB online to identify
and quantify each PL molecular species using the internal as a
reference for each class. The mass of target lipids and abundances
of their isotopic variants were calculated from the chemical
formula by adding the masses of the formate adduct ions
[M+CHO2]- as described in detail by Emmerich et al. (2017).
An independent reference sample was added to each run to
control for run-to-run variability. All molecular species identified
within each PL class were summed to generate total PC, LPC,
PE, LPE, SM, and PI concentration values. Each phospholipid
class of PC, LPC, PE, LPE, and PI was then separately grouped
according to their degree of unsaturation of each molecular
species saturated fatty acids (SFA), monounsaturated fatty acids
(MUFA), and polyunsaturated fatty acids (PUFA). We also
grouped arachidonic acid (AA)-containing lipid species to
docosahexaenoic acid (DHA)– and ether containing species of
PC, LPC, PE, LPE, and PI as described elsewhere (Emmerich
et al., 2017).
Statistical Plan
We determined differences in TBI or AD groups using
ANOVA or χ2 test. Samples were log transformed when
parametric assumptions were not met following tests for
normality. In cases when transformation was unsatisfactory, non-
parametric testing was used for analyses. We performed Principal
Component Analysis (PCA) to minimize multicollinearity and
to thus achieve dimension reduction, as we have previously
described for the analyses of our lipidomic datasets (Abdullah
et al., 2012, 2013, 2014). Individual lipids were analyzed
by mixed linear modeling (MLM) regression analysis to
identify lipids specifically altered by the study treatment. Prior
to performing MLM regression analysis on each relevant
component of interest (i.e., our outcome measure), we used
the Anderson-Rubin method to export uncorrelated scores,
whilst adjusting for random (i.e., human) factors, and to
assess independent (i.e., diagnostic and replicative) fixed factors.
Following analyses using MLM, Fischer’s least significant
difference (LSD) correction and the Benjamini–Hochberg (B–
H) procedure were used for multiple-test correction, and
control of the false discovery rate (set at 0.01) for all
comparisons. Analyses was conducted using SPSS version 17
(IBM corporation) and type I error was controlled by setting α
at 0.05.
RESULTS
Phospholipid Profiles in the Cortex and
Hippocampus of a r-mTBI (hTau) Mouse
Model
Total Phospholipid Levels in the Cortex and
Hippocampus of r-mTBI Mice at Longitudinal
Timepoints
The cortex and hippocampus are region that demonstrates
significant pathobiological changes in both TBI and
AD pathogenesis. We therefore analyzed different total
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FIGURE 1 | Total Phospholipid levels in the cortex of r-mTBI hTau mice. Significant changes in total phospholipid [PI (A), SM (B), PE (C), LPE (D), PC (E), LPC (F)]
species in the cortex of a model of repetitive-mTBI in hTau mice. Sample size for all groups across all time points is n = 4. All data represent mean µM per (10 mg)
wet weight ±SEM. Individual molecular lipid species were quantified by liquid chromatography/mass spectrometry and were summed after LipidomeDB analyses to
generate total phospholipid levels. Asterisks represent +P < 0.05, ++P < 0.01, +++P < 0.001 for comparisons between sham/r-mTBI mice. PE,
phosphatidylethanolamine; LPE, lysophosphatidylethanolamine; PC, phosphatidylcholine; LPC, lysophosphatidylcholine; PI, phosphatidylinositol; SM, sphingomyelin.
phospholipid species in this brain region of our mouse model.
In the cortex, total phosphatidylinositol (PI), PE, PC and
sphingomyelin (SM) were significantly increased at 24 h post-
injury in r-mTBI mice compared to sham counterparts
(Figures 1A–C,E). Total lysophosphatidylethanolamine
(LPE) and lysophosphatidylcholine (LPC) were decreased
at 3 months post-injury compared to shams their counterparts
(Figures 1D,F).
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FIGURE 2 | Total Phospholipid levels in the hippocampus of r-mTBI hTau mice. Significant changes in total phospholipid [PI (A), SM (B), PE (C), LPE (D), PC (E),
LPC (F)] species in the hippocampus of a model of repetitive-mTBI in hTau mice. Sample size for all groups across all time points is n = 4. All data represent mean
µM per (5.5 mg) wet weight ±SEM. Individual molecular lipid species were quantified by liquid chromatography/mass spectrometry and were summed after
LipidomeDB analyses to generate total phospholipid levels. Asterisks represent +P < 0.05, ++P < 0.01, +++P < 0.001 for comparisons between sham/r-mTBI
mice. PE, phosphatidylethanolamine; LPE, lysophosphatidylethanolamine; PC, phosphatidylcholine; LPC, lysophosphatidylcholine; PI, phosphatidylinositol; SM,
sphingomyelin.
Examination of total phospholipid levels in the hippocampus,
also revealed a significant increase in SM (at 24 h and 3 months
post-injury – Figure 2B), PE and PC (at 24 h post-injury –
Figures 2C,E), in repetitive mTBI mice compared to sham
counterparts. However, unlike changes observed in the cortex,
we observed a significant increase in LPE and LPC (at 24 h and
9 months post-injury – Figures 2D,F) in repetitive mTBI mice
compared to sham counterparts. Additionally, no change was
observed in total PI in the hippocampus of r-mTBI mice vs. Sham
counterparts at all timepoints examined (Figure 2A).
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FIGURE 3 | Total ether PE and ether PC levels in the cortex of repetitive-mTBI hTau mice. Significant changes in total etherPE (A) and etherPC (B) lipid species in
the cortex of a model of repetitive-mTBI in hTau mice. Sample size for all groups across all time points is n = 4. All data represent mean µM per (10 mg) wet weight
±SEM. Individual molecular lipid species were quantified by liquid chromatography/mass spectrometry and were summed after LipidomeDB analyses to generate
total etherphospholipid levels. Asterisks represent +P < 0.05 for comparisons between sham/r-mTBI mice. ePE, etherphosphatidylethanolamine; ePC,
etherphosphatidylcholine.
Total Ether PE and Ether PC Levels in the Cortex and
Hippocampus of Repetitive-mTBI Mice at
Longitudinal Timepoints
Given the changes observed in both PE and PC species,
we therefore proceeded to analyze the derivatives of total
PE and PC in the cortices and hippocampi of our TBI
models as they are physiologically relevant phospholipid species
which impact on brain function. In the cortex, there was
a significant increase in total ether-phosphatidylethanolamine
(ePE) and ether-phosphatidylcholine (ePC) at 24 h post-
injury in r-mTBI mice vs. shams (Figures 3A,B). Similarly,
investigation of hippocampal homogenates revealed a significant
increase in total ether-phosphatidylethanolamine (ePE) and
ether-phosphatidylcholine (ePC) at the 24 h post-injury time
point in r-mTBI mice vs. shams (Figures 4A,B).
Arachidonic Acid (AA) and Docosahexaenoic Acid
(DHA) Containing Phospholipid Species, and Their
Ratio in the Cortex and Hippocampus of Repetitive
mTBI Mice at Longitudinal Timepoints
In the cortex, we observed a significant increase in AA levels
for PI and PC species at the 24 h post-injury time point in the
repetitive mTBI vs. sham mice (Figures 5A,E), and a significant
decrease in AA levels for LPC was also observed at the 3 months
post-injury time point in the repetitive mTBI vs. sham mice
(Figure 5G). DHA levels for PI and LPC in the cortex were
significantly decreased at 3 months post-injury in repetitive-
mTBI compared to aged matched sham mice (Figures 5B,H),
however, there was an increase in DHA levels for PC at 24 h
post-injury in the repetitive mTBI vs. sham mice (Figure 5F). No
change was observed for AA and DHA levels for PE species in
repetitive mTBI vs. sham mice (Figures 5C,D).
Our interrogation of the hippocampus revealed a similar
changes observed in the cortex for AA and DHA levels for PC
species at 24 h, including also at 9 months post-injury time points
in repetitive mTBI vs. sham mice, but diverging effects were
observed in the hippocampus for AA and DHA levels for LPC
typified by a significant increase also at 24 h and 9 months post-
injury in repetitive mTBI vs. sham mice (Figures 6E–H). We did
not observe any change for AA and DHA levels for both PI and
PE species in the hippocampus in repetitive mTBI vs. sham mice
at any of the time points examined (Figures 6A–D).
Arachidonic acid (AA) and docosahexaenoic acid (DHA) are
polyunsaturated fatty acids, with prominent pro-inflammatory
and anti-inflammatory potential in the brain milieu, respectively.
We thus analyzed the levels of AA to DHA containing
phospholipid species (namely PE, PC, LPC, and PI) and their
relative ratio in both of our models. Notably, we observed a
significant increase in the AA to DHA ratio for PE and PI
species in the cortex at 24 h and 3 months, respectively, following
repetitive mTBI compared to shams (Table 1), with no change in
AA to DHA ratio for PC or LPC observed following any of the
post-injury timepoints we examined (Table 1).
In the hippocampus, we observed a significant increase in AA
to DHA ratio for PC species at 24 h, 3 and 6 months post-injury,
and also for PE species an increase at 3 months post-injury time
point in repetitive mTBI compared to sham mice (Table 2). No
changes in the AA to DHA ratio for PI and LPC species were
observed at any of the time points examined (Table 2).
Polyunsaturated, Monounsaturated and Saturated
Fatty Acid Containing Phospholipid Species in the
Cortex and Hippocampus of Repetitive mTBI Mice
The degree of fatty acid (FA) saturation can influence the function
of FA in a variety of ways, thus we proceeded to interrogate
monounsaturated, polyunsaturated and saturated fatty acid
containing phospholipid species in the cortices and hippocampi
of our mouse models. In the cortex, polyunsaturated fatty acid
(PUFA) containing PC and PI were significantly increased at
24 h post-injury timepoint in repetitive mTBI compared to
sham mice (Table 1), with no changes were observed for PUFA
containing PE or LPC following repetitive mTBI (Table 1).
In the hippocampus, PUFA containing PC, PE and LPC were
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FIGURE 4 | Total etherPE and ether PC levels in the hippocampus of repetitive-mTBI hTaumice. Significant changes in total etherPE (A) and etherPC (B) lipid
species in the hippocampus etc. of a model of repetitive-mTBI in hTau mice. Sample size for all groups across all time points is n = 4. All data represent mean µM
per (5.5 mg) wet weight ±SEM. Individual molecular lipid species were quantified by liquid chromatography/mass spectrometry and were summed after LipidomeDB
analyses to generate total etherphospholipid levels. Asterisks represent +P < 0.05, ++P < 0.01 for comparisons between sham/r-mTBI mice. ePE,
etherphosphatidylethanolamine; ePC, etherphosphatidylcholine.
significantly increased at 24hrs post-injury in repetitive mTBI
compared to sham mice (Table 2).
In the cortex, monounsaturated fatty acid (MUFA) containing
PC, PE, PI, and SM were significantly increased at 24 h post-
injury in repetitive mTBI compared to sham mice (Table 3),
while in the hippocampus, MUFA containing PC and PE were
significantly increased at 24 h post-injury, and MUFA containing
SM was significantly increased at both 24 h and 3 months post-
injury in repetitive mTBI compared to sham mice (Table 4).
Interrogation of the cortical tissue revealed that saturated fatty
acid (SFA) containing PC, PI, and SM were significantly increased
at 24 h post-injury in repetitive mTBI compared to sham mice
(Table 5), while SFA containing PE species were unchanged
following injury (Table 5).
In the hippocampus, similar changes were observed for
SFA and MUFA containing PC, PE, and SM species. We
observed a significant increase in SFA containing PC and
PE at 24 h post-injury in repetitive mTBI compared to
sham mice (Table 6). SFA containing SM were significantly
increased at 24 h and 3 months post-injury in repetitive
mTBI compared to sham mice (Table 6). However, no
significant change was observed for PUFA, MUFA, or SFA
containing PI species following repetitive mTBI (see Tables 2, 4,
6).
See Supplementary Tables S1–S5 for changes in individual
molecular species for each phospholipid class (PC, PE, LPE, PI,
and SM) in the cortex of our r-mTBI hTau mouse model.
See Supplementary Tables S6–S10 for changes in individual
molecular species for each phospholipid class (PC, LPC, PE, LPE,
PI, and SM) in the hippocampus of our r-mTBI hTau mouse
model.
DISCUSSION
We previously demonstrated in a moderate to severe-TBI mouse
model (CCI) the involvement of several phospholipid species
in the pathogenesis of TBI, 3 months post-injury (Abdullah
et al., 2014). At the outset of this project we sought to further
investigate the role of phospholipids in repetitive mTBI in a
larger and comprehensive study. To address this, we have used
a lipidomic approach in a longitudinal study involving five
extended time points (ranging from 24 h to 12 months post-
injury) following repetitive mild injury in our preclinical mouse
model. Such an extended chronic time point evaluation has not
been previously explored, and is important in understanding the
underlying neurobiological sequelae of TBI pathogenesis. The
behavioral and histopathological outcomes in our established
preclinical mouse model have been previously characterized at
acute (24 h) to chronic (12 months) time points post-injury.
Hallmark features include: persistent white matter changes,
typified by corpus callosum thinning, glial activation, and deficits
in spatial learning and memory (Mouzon et al., 2012, 2014).
Given the involvement of tau protein as a key player in the
human pathogenesis of repetitive mTBI (Omalu et al., 2011;
McKee et al., 2013), we have chosen to use hTau mice, which
express all six human tau isoforms on a null murine background
to closely mimic the human condition (Andorfer et al., 2003).
Emerging neurological and histopathological features have been
well characterized in these mice. Human Tau mice progressively
develop hyperphosphorylated and aggregated tau as early as
9 months and by 15 months of age show evidence of thioflavine-
s positive neurofibrillary tangles. Cognitive deficits in normal
object recognition and Morris water maze test appear around
12 months of age and get progressively worse (Andorfer et al.,
2003; Polydoro et al., 2009). We have thus chosen to explore
timepoints encompassing pre-, peri- and post-“onset” of the
cognitive and neuropathological phenotypes, and timepoints
post-injury (i.e., 24 h, 3, 6, 9, and 12 months) that capture the
anticipated responses overlapping with AD pathogenic changes.
Animals were exposed to their injuries at young adulthood
(approximately 3 months of age), prior to the emergence of
neuropathological features, as this is the vulnerable age-group
(e.g., athletes involved in contact sports and military personnel)
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FIGURE 5 | Arachidonic acid and docosahexaenoic acid containing phospholipid species in the cortex of repetitive mTBI hTau mice. Significant changes in
arachidonic acid and docosahexaenoic acid containing PI (A,B), PE (C,D), PC (E,F), and LPC (G,H) species in the cortex of a model of repetitive-mTBI in hTau mice.
Sample size for all groups across all time points is n = 4. Data represents mean µmol per wet weight (10 mg) ±SEM. Individual molecular lipid species were
quantified by liquid chromatography/mass spectrometry and were summed after LipidomeDB analyses to generate arachidonic and docosahexaenoic acid levels for
each phospholipid species. Asterisks represent +P < 0.05, ++P < 0.01, +++P < 0.001 for comparisons between sham/r-mTBI mice. PE,
phosphatidylethanolamine; PC, phosphatidylcholine; PI, phosphatidylinositol.
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FIGURE 6 | Arachidonic acid and docosahexaenoic acid containing phospholipid species in the hippocampus of repetitive mTBI hTau mice. Significant changes in
arachidonic acid and docosahexaenoic acid containing PI (A,B), PE (C,D), PC (E,F), and LPC (G,H) species in the hippocampus of a model of repetitive-mTBI in
hTau mice. Sample size for all groups across all time points is n = 4. Data represent mean µmol per wet weight (5.5 mg) ±SEM. Individual molecular lipid species
were quantified by liquid chromatography/mass spectrometry and were summed after LipidomeDB analyses to generate arachidonic and decosahexaenoic acid
levels for each phospholipid species. Asterisks represent +P < 0.05, ++P < 0.01, +++P < 0.001 for comparisons between sham/r-mTBI mice. PE,
phosphatidylethanolamine; PC, phosphatidylcholine; PI, phosphatidylinositol; LPC, lysophosphatidylcholine.
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that we are attempting to mimic who are at risk of exposures
to repetitive injuries. hTau mice exposed to our repetitive
concussive injury paradigms show similar pathology to our wild-
type mice, including evidence of injury dependent acute (early
and transient) changes in phospho-tau pathology, without any
appreciable chronic and persistent tau pathology 1 year after
injury (Mouzon et al., 2012, 2014, 2018a,b). To date the influence
of human tau genetic background on brain phospholipids,
especially in the context of repetitive mTBI remains elusive.
We have focused our investigations herein on six major types
of phospholipids: PC, lysophosphatidylcholine (LPC), PI, PE,
lysophosphatidylethanolamine (LPE) and sphingomyelin (SM) –
see Figure 7.
In the cortex and hippocampus, we report a significant
increase in PC and PE at the acute (24 h) time point alone. Tau
(human) which is found in membrane rich neuronal structures
has been previously shown to interact with the inner leaflet of
phospholipid plasma membranes in different in vitro models;
these phospholipids can modulate tau phosphorylation, facilitate
tau aggregation and secretion by trans-cellular spreading in vivo,
and may serve as a pathway for tau aggregates to exert
toxicity (Baudier and Cole, 1987; Shea, 1997; Katsinelos et al.,
2018). In human AD brains, tangle bearing neurons have been
shown to demonstrate increased immunoreactivity for lipid
rafts associated proteins derived from lysosomes, PC levels have
also been observed in purified paired helical filaments, and
given the involvement of tau in transport of vesicles along
microtubule tracks, suggests their role in altered subcellular
vesicular transport of lipids (Girardot et al., 2003; Gellermann
et al., 2006).
We postulate that the increase we observed in phospholipid
levels in our model could thus indicate an increased propensity
for tau aggregation after repetitive concussions, which appears to
occur very early (and transiently) in our model, albeit without
other influencing factors in vivo (Mouzon et al., 2018a,b).
Persistent and chronic tau pathology following TBI in young
mice is not a feature of this injury paradigm, however, this has
been observed in aged mice using the same injury model (Ojo
et al., 2013), and also in a chronic repetitive mTBI paradigm
involving 32 hits over 3 months (Ojo et al., 2016), and we thus
anticipate that we will observe more prominent changes in the
brain lipid profiles of these models. Although no changes in PC
and PE were evident between 3 and 12 months post-injury, we did
observe a notable decrease in both their derivatives, lysoPE and
lyso PC, respectively, at 3 months post-injury in the cortex, and
an increase at 24 h and 9 months in the hippocampus of injured
mice. This suggests that the early changes in the cortex may
primarily be a consequence of injury, whilst the more chronic
alterations in the hippocampus may be secondary and related to
inflammation. With respect to the latter lysoPC is a strong pro-
inflammatory mediator that can act via platelet activating factor
(PAF) receptor to release arachidonic acid and downstream pro-
inflammatory eicosanoids leading to hippocampal dysfunction,
as we have observed in hippocampal dependent tasks in our
model at chronic time points (Oestvang et al., 2011; Mouzon
et al., 2014, 2018a,b). The differential effects in the cortex and
hippocampus also seem to implicate possible changes in the
net hydrolysis of PC and PE by phospholipase (PL) enzymes
such as PLA2 and PLD following TBI in the hippocampus and
cortex. The reason behind these localized regional brain changes
observed at different time points in the hippocampus and cortex
is currently unknown, but could indicate regional differences in
lipid metabolism. It is also noteworthy in light of the diagnostic
and therapeutic implications that we have focused our analyses
on the whole cortex, and because our injury was performed on
the mid-sagittal suture (localized to the parietal cortex), it is also
possible that there might be an existence of a different lipid profile
in different cortical regions, of which we are unable to determine
in this current study.
Intriguingly, in a previous study examining wild-type mice
exposed to the same experimental injury paradigm, a significant
increase in these phospholipids (PC and PE) was also observed
at acute time points post-injury in the cortex (Ojo et al.,
2018). However, this was also accompanied by a significant
increase at chronic time points (6–12 months) post-injury
(Ojo et al., 2018). The reason behind this differential effect
is unknown, but it is possible that these differences may be
related to the underlying signaling processes activated by human
tau in a murine background that normally expresses 3 repeat
tau isoforms. Our previous behavioral and histopathological
examination of animals appeared to indicate similar outcomes
in spatial learning and memory, including glial and axonal
pathology in both WT and hTau experimental models of
repetitive mTBI (Mouzon et al., 2012, 2014, 2018a,b; Ojo et al.,
2018). A closer assessment of other biochemical events will
be required to address the differential effects exerted by the
introduction of human vs. murine tau background and its impact
on phospholipid metabolism, signaling and transport, and other
lipid parameters such as small dense Low Density Lipoprotein,
oxidized Low Density Lipoprotein, Apolipoproteins etc. Further
studies will also be required to examine the consequences of early
phospholipid changes on the integrity and behavior of neurons,
glia and cerebrovascular cell function.
Our findings reported here are consistent with the human
literature, whereby an immediate and significant increase in
phospholipid levels in the CSF has been shown in patients
exposed to severe TBI (Kay et al., 2003). In other mouse
models of severe TBI, similar elevations in both phospholipids
and their metabolites have likewise been demonstrated in the
hippocampus and cortices of rodents following CCI at acute
and sub-acute time points, respectively (Homayoun et al., 1997,
2000; Abdullah et al., 2014). Explanations for the immediate
rise in phospholipid levels after TBI are unknown but could
be attributed to repair of damaged phospholipid membranes
and an early response to injury. Dysregulation in metabolic
and catabolic processing of phospholipids and dysfunction in
peroxisome mediated synthesis of phospholipids are possible
mechanisms, but further biochemical investigations and a whole
scale systemic approach are required to confirm this. It is known
that blood brain barrier perturbations and reduction in cerebral
perfusion is an early event following TBI (Amen et al., 2016)
and this may contribute toward early and transient deleterious
effects on brain lipid transport mechanism. It is also noteworthy
that early increases in total PC and PE seem to resolve very
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TABLE 3 | Monounsaturated fatty acid containing phospholipid species in the cortex of repetitive mTBI hTau mice.
Monounsaturated fatty acid containing lipid species
Phosphatidylcholine Phosphatidylethanolamine Phosphatidylinositol Sphingomyelin
(PC) (PE) (PI) (SM)
Mean SEM Mean SEM Mean SEM Mean SEM
24H 149.247 3.135 22.347 0.450 1.636 0.048 3.586 0.130
3M 152.515 7.635 22.027 0.999 1.471 0.115 6.959 0.623
SHAM 6M 158.090 10.206 22.682 0.622 1.782 0.123 6.116 0.484
9M 164.483 6.967 25.139 0.785 1.732 0.176 6.779 0.307
12M 153.752 4.217 25.161 0.588 2.133 0.113 6.542 0.373
24H 169.37+++ 3.328 25.397+ 0.330 2.251++ 0.080 4.925++ 0.222
3M 149.444 5.736 21.648 0.668 1.516 0.079 6.717 0.214
r-mTBI 6M 149.670 4.397 21.133 2.005 1.538 0.102 7.087 0.089
9M 154.273 8.622 22.426 1.108 1.634 0.125 6.000 0.447
12M 154.352 2.581 25.300 0.815 2.089 0.093 6.271 0.383
Significant changes in monounsaturated fatty acid containing PC, PE, PI, and SM species in the cortex of repetitive mTBI hTau mice. Sample size for all groups across all
time points is n = 4. All data represent mean µM per (10 mg) wet weight ±SEM. Individual molecular lipid species were quantified by liquid chromatography/mass
spectrometry and were summed after LipidomeDB analyses to generate monounsaturated fatty acid classification for each phospholipid species was compiled
from these values. Asterisks represent +P < 0.05, +++P < 0.01, +++P < 0.001 for comparisons between sham/r-mTBI mice. PE, phosphatidylethanolamine; PC,
phosphatidylcholine; PI, Phosphatidylinositol; SM, sphingomyelin.
TABLE 4 | Monounsaturated fatty acid containing phospholipid species in the cortex of repetitive mTBI hTau mice.
Monounsaturated fatty acid containing lipid species
Phosphatidylcholine Phosphatidylethanolamine Phosphatidylinositol Sphingomyelin
(PC) (PE) (PI) (SM)
Mean SEM Mean SEM Mean SEM Mean SEM
SHAM 24H 63.673 4.493 8.923 0.544 5.522 0.933 1.024 0.093
3M 61.204 4.354 8.723 0.289 6.531 1.065 1.673 0.114
6M 82.151 7.063 10.935 0.767 7.120 1.100 2.272 0.112
9M 74.872 5.334 10.827 0.472 6.733 1.094 1.910 0.076
12M 76.644 5.844 11.771 0.578 6.691 1.021 2.009 0.099
r-mTBI 24H 88.344+ 8.963 12.035+ 0.761 7.443 1.241 1.509+ 0.073
3M 69.087 6.618 9.672 0.694 6.402 1.099 2.051+ 0.134
6M 73.181 4.264 10.459 0.516 7.099 1.217 2.364 0.193
9M 84.734 5.944 11.883 0.468 7.385 1.191 2.165 0.079
12M 74.950 4.091 11.173 0.534 6.943 1.207 2.049 0.131
Significant changes in monounsaturated fatty acid containing PC, PE, PI, and SM species in the hippocampus of repetitive mTBI hTau mice. Sample size for all groups
across all time points is n = 4. All data represent mean µM per (5.5 mg) wet weight±SEM. Individual molecular lipid species were quantified by liquid chromatography/mass
spectrometry and were summed after LipidomeDB analyses to generate monounsaturated fatty acid classification for each phospholipid species was compiled from these
values. Asterisks represent +P < 0.01 for comparisons between sham/r-mTBI mice. PE, phosphatidylethanolamine; PC, phosphatidylcholine; PI, phosphatidylinositol;
SM, sphingomyelin.
early in our model, however, the consequences of the early
events triggered by this rise is unknown. Phospholipids can
be converted into downstream and bioactive lipids which can
activate a complex downstream cascades of events that can
be reparative or detrimental to cellular function. We tried to
partially address this question herein, by examining the levels of
PE and PC derivatives in our models, including the degree of
saturation of different phospholipids.
We observed changes in etherPE (and etherPC) in the cortex
and hippocampus at acute time points post-injury in our model.
These lipids, particularly plasmalogens [etherPE (38:6); (40:4);
(40:5); (40:6)] that contain O-alk-1-enyl at the sn1 position,
generally contain more PUFA and play a role in cholesterol
esterification and maintenance of myelin surrounding axonal
nodes (Gorgas et al., 2006; Mankidy et al., 2010). Plasmalogens
specifically play a vital role in vesicle formation and membrane
fusion and therefore may also affect neurotransmitter release
following TBI (Lohner, 1996). Over production of these lipid
species could therefore have damaging consequences in neuronal
signaling and may lead to dysfunction in neurotransmitter
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TABLE 5 | Saturated fatty acid containing phospholipid species in the cortex of repetitive mTBI hTau mice.
Saturated fatty acid containing lipid species
Phosphatidylcholine Phosphatidylethanolamine Phosphatidylinositol Sphingomyelin
(PC) (PE) (PI) (SM)
Mean SEM Mean SEM Mean SEM Mean SEM
SHAM 24H 109.539 2.198 41.258 0.993 0.837 0.024 3.118 0.111
3M 107.633 4.471 37.153 1.793 0.853 0.051 3.841 0.202
6M 110.241 5.261 36.196 0.822 0.961 0.030 3.597 0.138
9M 110.233 4.062 39.737 1.581 1.216 0.231 4.096 0.172
12M 103.763 3.476 39.541 0.724 1.082 0.038 4.009 0.183
r-mTBI 24H 122.238++ 2.456 45.013 0.756 1.099++ 0.036 3.897++ 0.096
3M 102.358 3.982 36.492 1.472 0.972 0.173 3.644 0.136
6M 104.050 2.154 35.985 3.534 0.841 0.079 3.964 0.122
9M 106.649 4.923 36.164 1.633 0.845 0.052 3.807 0.265
12M 107.599 1.448 40.187 0.867 1.145 0.052 4.189 0.133
Significant changes in saturated fatty acid containing PC, PI, PE, and SM species in the cortex of repetitive mTBI hTau mice. Sample size for all groups across all time
points is n = 4. All data represent mean µM per (10 mg) wet weight ±SEM. Individual molecular lipid species were quantified by liquid chromatography/mass spectrometry
and were summed after LipidomeDB analyses to generate saturated fatty acid classification for each phospholipid species was compiled from these values. Asterisks
represent ++P< 0.01 for comparisons between sham/r-mTBI mice. PE, phosphatidylethanolamine; PC, phosphatidylcholine; PI, phosphatidylinositol; SM, sphingomyelin.
TABLE 6 | Saturated fatty acid containing phospholipid species in the cortex of repetitive mTBI hTau mice.
Saturated fatty acid containing lipid species
Phosphatidylcholine Phosphatidylethanolamine Phosphatidylinositol Sphingomyelin
(PC) (PE) (PI) (SM)
Mean SEM Mean SEM Mean SEM Mean SEM
SHAM 24H 48.923 3.813 17.882 1.021 4.308 0.761 5.707 0.294
3M 43.756 3.855 15.200 0.813 5.873 1.091 9.066 0.324
6M 56.077 5.114 18.305 1.284 6.368 1.077 12.695 0.564
9M 49.840 4.353 17.084 1.042 5.300 0.856 9.682 0.152
12M 51.046 3.970 17.834 0.916 5.724 0.927 10.149 0.266
r-mTBI 24H 63.091+ 6.358 21.793+ 1.521 5.565 0.971 9.492+ 0.212
3M 47.998 5.000 16.071 1.221 5.004 0.875 10.384+ 0.462
6M 50.444 3.149 17.430 0.749 5.997 0.992 12.606 0.727
9M 58.297 4.682 18.543 0.960 6.223 1.025 11.370 0.333
12M 50.875 3.476 17.780 0.777 6.071 1.036 10.510 0.406
Significant changes in saturated fatty acid containing PC, PE, PI, and SM species in the hippocampus of repetitive mTBI hTau mice. Sample size for all groups across
all time points is n = 4. All data represent mean µM per (5.5 mg) wet weight ±SEM. Individual molecular lipid species were quantified by liquid chromatography/mass
spectrometry and were summed after LipidomeDB analyses to generate saturated fatty acid classification for each phospholipid species was compiled from these
values. Asterisks represent +P < 0.01 for comparisons between sham/r-mTBI mice. PE, phosphatidylethanolamine; PC, phosphatidylcholine; PI, phosphatidylinositol;
SM, sphingomyelin.
systems ubiquitous to the brain, such as glutamatergic systems.
Glutamate excitotoxicity has been previously reported in TBI
models in vivo (Yi and Hazell, 2006), and changes in etherPE,
amongst other factors, may contribute to this biochemical event
following injury.
In our TBI model we also observed a significant increase
in sphingomyelin in the cortex and hippocampus at an early
time point post-injury. We previously showed similar changes
at acute (but also chronic) time points post-injury in wild type
mice within the hippocampus of animals exposed to the same
experimental r-mTBI paradigm (Ojo et al., 2018) and also in a
CCI model (Abdullah et al., 2014). Sphingomyelin is a type of
sphingolipid found in cell membranes and is associated with lipid
microdomains or lipid rafts which influence cellular processes
such as membrane sorting, trafficking and cell polarization
(Wenk, 2010; Kosicek and Hecimovic, 2013). Sphingomyelin is
also found in the membranous myelin sheath that surrounds
some nerve cell axons. Axons become sheared following repeated
mTBI, and this can be accompanied by disruptions and
irregularities in myelin ensheathment of axons (Ojo et al., 2015).
Increase in sphingomyelin may therefore indicate the activation
of reparative processes involving membrane resorting, cellular
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FIGURE 7 | Schematic diagram of key phospholipids investigated and their metabolites. Lipids investigated are highlighted in blue typescript. Phosphatidylinositol -
4 – phosphate [PI-4-P]; Phosphatidylinositol – 4, 5- bisphosphate [PI-4,5-P2]; Inositol trisphosphate [Ins (1,4,5)P3]; Diglyceride [DAG]; Phosphatidylethanolamine
N-methyltransferase [PEMT]; Phospholipase A2 [PLA2]; Phosphatidylinositol – 3, 4- bisphosphate [PI- 3,4-P2]; Phosphatidylinositol -3- bisphosphate [PI-3-P].
trafficking and remyelination of damage axons. Additionally,
sphingomyelin can also be metabolized to give rise to ceramides
and other potentially toxic bioactive lipid species involved in
apoptotic signaling. Whether this is a consequence of the increase
in sphingomyelin in our model remains unknown, further
measurement of downstream bioactive lipids will be need to
elucidate this.
We examined the degree of saturation of fatty acids for each
brain phospholipid species that we investigated in our mouse
model and found an increase in SFA, MUFA, and PUFA levels
in the cortex and hippocampus mainly at early time points (24 h
and 3 months) post-injury for most of the phospholipid species.
Degree of fatty acid saturation can influence the function of
fatty acids in a variety of ways which can impact on neuronal
and brain function. High intake of SFAs such as palmitic and
stearic acid for example has been associated with increased risk
for cardiovascular and neurodegenerative diseases, with evidence
indicating increased tau hyperphosphorylation and increased
expression of the amyloid beta generating enzyme, BACE1 (Patil
et al., 2008). The source of this increase in SFA in our model
is unknown (as all animals were on the same diet), but could
be attributed to several reasons, such as: a lower capacity of
neurons to metabolize SFAs, an increase in their synthesis in the
brain or altered transport mechanisms into the brain that is TBI
dependent (Spector, 1988a,b).
Monounsaturated fatty acids (MUFA) are a common part
of Mediterranean diets and have long been associated with
neuroprotective properties (Carrillo et al., 2012). In the brain the
main MUFA is oleic acid, and it is found in neuronal membranes
and in high levels in myelin (Bazinet and Laye, 2014). In vivo
and in vitro studies have reported oleic acid’s ability to inhibit
oxidative stress, promote anti-inflammatory/neurotropic support
and mitigate AD pathology (Medina and Tabernero, 2002; Amtul
et al., 2011; Carrillo et al., 2012). Human studies examining the
CSF of patients exposed to TBI corroborate our findings, and
confirm a significant increase in oleic acid 48 h after injury
(Pilitsis et al., 2003). The increase in oleic acid observed at acute
time points could signal an attempt by the brain to repair itself
following TBI, and this is partly supported by the lack of overt
histopathological changes in the cortex at sub-acute time points
following injury in our experimental model (Mouzon et al., 2012,
2014). The source of increase in MUFA’s especially at an acute
time point may be directly related to the desaturation of brain
SFA’s which was also increased at this time point. Transit into the
brain from the periphery as a result of transient disruptions to the
BBB is also another plausible explanation.
The two most predominant PUFAs in the brain are omega-
6 arachidonic acid (AA) and omega-3 docosahexaenoic acid
(DHA). Arachidonic acid and docosahexaenoic acid each make
up approximately 10% of the total fatty acids within brain
phospholipids (Bazinet and Laye, 2014). In this study, within
the cortex we reveal a significant increase in AA containing
PI, PC and LPC at early time points post injury, and this
was accompanied by a reduction in DHA levels for PI and
LPC at 3 months post-injury. A significant increase in the
AA to DHA ratio for PE, PC, and PI was also shown at
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the earlier time points post-injury in the cortex. We have
previously reported a trend toward an increase in the AA
to DHA ratio in the cortex of a similar TBI paradigm in
wild-type mice at 3 and 6 months post-injury (Ojo et al.,
2018) and also in the cortex following a single severe CCI
TBI (Abdullah et al., 2014). In the hippocampus, we observed
a significant increase in both AA and DHA levels for PC
and LPC at the 24 h and 9 months post-injury time points;
while the ratio of AA to DHA was increased for PC and PE
species. These identified regional differences suggest that the
molecular profile of TBI-induced events in the hippocampus
and cortex may follow a different pathway, with a specific
role played by certain phospholipid species in localized brain
regions; but how this impacts on the pathogenesis of TBI is
currently unknown. Human studies, examining CSF of patients
exposed to TBI, also demonstrate an increase in PUFA and
arachidonic acid 1 week after insult and this was associated
with a worse outcome using the Glasgow Outcome Scale (Pilitsis
et al., 2003). Arachidonic acid is a mediator lipid derived
from long chain PUFAs; it is a precursor for downstream
end mediators such as eicosanoids and leukotrienes that are
produced in copious amounts by activated microglial cells in
the brain, and are main drivers of pro-inflammatory responses
and vascular permeability (Wenk, 2010). Decosahexaenoic acid
which comprises 97% of the brain omega-3 long chain PUFAs
is a precursor for end metabolites such as resolvins and
protectins which have a potent anti-inflammatory role even
at low nanomolar concentrations, including protection against
oxidative stress, apoptosis and stimulation of neurite outgrowth
and proliferation (Adibhatla and Hatcher, 2007; Ariel and
Serhan, 2007; Bazinet and Laye, 2014). The secondary injury
phase of TBI involves axonal injury mediated by shearing of
axons, which causes damage to neuronal lipid rich membranes
resulting in influx of calcium ions, depolarization of neurons
and glutamate excitotoxicity. Such biochemical cascades can
activate inflammatory processes leading to priming of glial cells
and release of neurotoxic lipid metabolites, pro-inflammatory
cytokines and free radical species (Bailes and Patel, 2014). This
is partly supported by the evidence from our studies implicating
an imbalance in AA to DHA ratio in our model. Increase in AA
levels can result in conversion to eicosanoids by cyclooxygenase
and lipoxygenase, which mediate pro-inflammatory processes,
resulting in persistent activation of glial cells which express
receptors that are sensitive to these bioactive lipids, thus resulting
in a self-perpetuating cycle of tissue damage. Parallel reductions
in DHA levels will also result in a decrease in their ability to yield
bioactive lipid metabolites, such as protectin (neuroprotectin
D1, resolvin), that can resolve inflammation and stimulate
neurotrophic support (Bailes and Patel, 2014). Persistent glial
activation and neuroinflammation in the white matter is a
prominent feature of our model. We have yet to investigate
the direct consequences of these changes in PUFAs in our
model, and further work is planned to explore these possibilities,
particularly focusing on downstream AA and DHA pathways.
Thus from our findings it appears that dietary supplementation
with DHA or mitigation of downstream AA eicosanoid pathways,
especially at a therapeutic window within 3 months post
injury where we observed most changes in our model, may
offer a novel therapeutic approach to stimulate the brains
DHA dependent neuroprotective mechanisms. Beneficial effects
on neuroinflammation and behavioral outcomes have been
previously shown in an animal model of concussion (acceleration
and deceleration) with DHA supplementation (Bailes and Mills,
2010).
In this study we have conducted a comprehensive assessment
of lipid profiles following TBI in the hTau mouse model over a
longitudinal time scale. Our data indicate a significant increase
at early time points post-injury in phospholipids, and elevations
in the Omega-6 to Omega-3 fatty acid ratio. We propose that
targeting these phospholipids and their bioactive metabolites
offers a novel therapeutic approach in TBI, especially during
the optimal therapeutic window for recovery of the normal
lipid profile. Further studies using human samples (postmortem
tissue, ISF/CSF, or plasma at different staging of pathogenesis)
will be needed to translate our preclinical findings into the
heterogeneous human TBI population. Moreover, additional
investigations of how these brain specific changes may influence
blood lipid profiles will be vital, as they may help to identify
putative peripheral biomarkers of TBI, especially at early (acute
to sub-acute) time points post-injury.
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Table S1 | Phosphatidylinositol lipid species in the cortex of r-mTBI mice.
Significant changes in individual species containing phosphatidylinositol after
repetitive mTBI in hTau mice. Sample size for all groups across all time points is
n = 4. All data represent mean µM per (10 mg) wet weight ±SEM. Individual
molecular lipid species were quantified by liquid chromatography/mass
spectrometry. Highlighted boxes show significantly regulated levels (P < 0.01)
between repetitive-mTBI/sham mice based on mixed linear modeling regression
analysis.
Table S2 | Phosphatidylethanolamine lipid species in the cortex of r-mTBI mice.
Significant changes in individual species containing phosphatidylethanolamine
after repetitive mTBI in hTau mice. Sample size for all groups across all time points
is n = 4. All data represent mean µM per (10 mg) wet weight ±SEM. Individual
molecular lipid species were quantified by liquid chromatography/mass
spectrometry. Highlighted boxes show significantly regulated levels (P < 0.01)
between repetitive-mTBI/sham mice based on mixed linear modeling regression
analysis.
Table S3 | Lysophosphatidylethanolamine lipid species in the cortex of r-mTBI
mice. Significant changes in individual species containing
lysophosphatidylethanolamine after repetitive mTBI in hTau mice. Sample size for
all groups across all time points is n = 4. All data represent mean µM per (10 mg)
wet weight ±SEM. Individual molecular lipid species were quantified by liquid
chromatography/mass spectrometry. Highlighted boxes show significantly
regulated levels (P < 0.01) between repetitive-mTBI/sham mice based on mixed
linear modeling regression analysis.
Table S4 | Phosphatidylcholine lipid species in the cortex of r-mTBI mice.
Significant changes in individual species containing phosphatidylcholine after
repetitive mTBI in hTau mice. Sample size for all groups across all time points is
n = 4. All data represent mean µM per (10 mg) wet weight ±SEM. Individual
molecular lipid species were quantified by liquid chromatography/mass
spectrometry. Highlighted boxes show significantly regulated levels (P < 0.01)
between repetitive-mTBI/sham mice based on mixed linear modeling regression
analysis.
Table S5 | Sphingomyelin lipid species in the cortex of r-mTBI mice. Significant
changes in individual species containing sphingomyelin after repetitive mTBI in
hTau mice. Sample size for all groups across all time points is n = 4. All data
represent mean µM per (10 mg) wet weight ±SEM. Individual molecular lipid
species were quantified by liquid chromatography/mass spectrometry. Highlighted
boxes show significantly regulated levels (P < 0.01) between
repetitive-mTBI/sham mice based on mixed linear modeling regression analysis.
Table S6 | Phosphatidylethanolamine lipid species in the hippocampus of r-mTBI
mice. Significant changes in individual species containing
phosphatidylethanolamine after repetitive mTBI in hTau mice. Sample size for all
groups across all time points is n = 4. All data represent mean µM per (5.5 mg)
wet weight ±SEM. Individual molecular lipid species were quantified by liquid
chromatography/mass spectrometry. Highlighted boxes show significantly
regulated levels (P < 0.01) between repetitive-mTBI/sham mice based on mixed
linear modeling regression analysis.
Table S7 | Lysophosphatidylethanolamine lipid species in the hippocampus of
r-mTBI mice. Significant changes in individual species containing
lysophosphatidylethanolamine after repetitive mTBI in hTau mice. Sample size for
all groups across all time points is n = 4. All data represent mean µM per (5.5 mg)
wet weight ±SEM. Individual molecular lipid species were quantified by liquid
chromatography/mass spectrometry. Highlighted boxes show significantly
regulated levels (P < 0.01) between repetitive-mTBI/sham mice based on mixed
linear modeling regression analysis.
Table S8 | Phosphatidylcholine lipid species in the hippocampus of r-mTBI mice.
Significant changes in individual species containing phosphatidylcholine after
repetitive mTBI in hTau mice. Sample size for all groups across all time points is
n = 4. All data represent mean µM per (5.5 mg) wet weight ±SEM. Individual
molecular lipid species were quantified by liquid chromatography/mass
spectrometry. Highlighted boxes show significantly regulated levels (P < 0.01)
between repetitive-mTBI/sham mice based on mixed linear modeling regression
analysis.
Table S9 | Lysophosphatidylcholine lipid species in the hippocampus of r-mTBI
mice. Significant changes in individual species containing lysophosphatidylcholine
after repetitive mTBI in hTau mice. Sample size for all groups across all time points
is n = 4. All data represent mean µM per (5.5 mg) wet weight ±SEM. Individual
molecular lipid species were quantified by liquid chromatography/mass
spectrometry. Highlighted boxes show significantly regulated levels (P < 0.01)
between repetitive-mTBI/sham mice based on mixed linear modeling regression
analysis.
Table S10 | Sphingomyelin lipid species in the cortex of r-mTBI mice. Significant
changes in individual species containing sphingomyelin after repetitive mTBI in
hTau mice. Sample size for all groups across all time points is n = 4. All data
represent mean µM per (5.5 mg) wet weight ±SEM. Individual molecular lipid
species were quantified by liquid chromatography/mass spectrometry. Highlighted
boxes show significantly regulated levels (P < 0.001) between
repetitive-mTBI/sham mice based on mixed linear modeling regression analysis.
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